WebsEdge/Health

Presents

ADA TV 2020

WebsEdge/Health produced ADA TV covering the ADA 2020 Virtual Experience. Even though the conference didn't take place at a convention center ADA TV was still able to interview key speakers online and bring you all the up to date research and news on Diabetes.

vTv Therapeutics

Meeting Challenges in Type 1 Diabetes Management

vTv Therapeutics is a clinical stage biopharmaceutical company with a pipeline of first-in-class small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of diseases led by programs for the treatment of type 1 diabetes and Alzheimer’s disease. vTv has a long history of innovation and has discovered all of these molecules in-house. There are nearly 1.5 million people with type 1 diabetes in the US with no treatment options beyond insulin and amylin injections. TTP399 was originally developed for the treatment of type 2 diabetes, but vTv found a greater need for new treatment options for type 1 diabetes. TTP399 has an insulin-independent MOA, which makes it uniquely suited to type 1 diabetes.

Comments:

No comments yet... Be the first!

Post your comment:

Please read our comments policy before posting your comment. By pressing the "Submit Comment" button you agree to our privacy policy.
https://youtu.be/-fCiL0LnQV0 ADA TV Day 1 Highlights

ADA TV Day 1 Highlights

ADA TV

https://youtu.be/qvZjnhwJWY0 ADA TV Day 2 Highlights

ADA TV Day 2 Highlights

ADA TV

https://youtu.be/7CAgAjRIKkQ ADA TV Day 3 Highlights

ADA TV Day 3 Highlights

ADA TV

https://youtu.be/htn0Yb7qjcw ADA TV Day 4 Highlights

ADA TV Day 4 Highlights

ADA TV

https://youtu.be/kN76eMfjGbs ADA TV Day 5 Highlights

ADA TV Day 5 Highlights

ADA TV

Imcyse

Imcyse

Rethinking T1D: Saving Beta Cells with Targeted Immunotherapy

https://youtu.be/xFQ-djoTMPc Digital Diagnostics

Digital Diagnostics

Forging a New Path: Healthcare AI Done the Right Way

https://youtu.be/uKwGE29m4mw vTv Therapeutics

vTv Therapeutics

Meeting Challenges in Type 1 Diabetes Management

https://youtu.be/X-GlkjboJ54 Arkansas Children's Hospital

Arkansas Children's Hospital

Focus Determining Reality: Diabetes in Arkansas

https://youtu.be/K0gbsnoJDDE William Polonsky, PhD

William Polonsky, PhD

Providing Hope to People with Diabetes

https://youtu.be/6E3KzperR1o Jiandie Lin, PhD

Jiandie Lin, PhD

Signalling Pathways in Diabetes and Obesity

https://youtu.be/1MEFxHoWXaA Introducing ADA's New Chief Scientific & Medical Officer

Introducing ADA's New Chief Scientific & Medical Officer

Robert M. Gabbay, MD, PhD

Mary De Groot, PhD

Mary De Groot, PhD

Diabetes Care During COVID-19

https://youtu.be/ao48Ds2w5Pc Ele Ferrannini, MD

Ele Ferrannini, MD

Breakthroughs in Insulin Resistance

https://youtu.be/lYSvfE8B-Lc Robert H. Eckel, MD

Robert H. Eckel, MD

Diabetes and the USA

https://youtu.be/rTVzuoOdxck Phase 3 Clinical Trials - Hua Medicine

Phase 3 Clinical Trials - Hua Medicine

COVID-19 in China